基本信息
浏览量:538
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
He was a Pelican Cancer Foundation Research Fellow followed by a MRC Clinician Research Training fellowship at University College London at which time a number of imaging and focal therapy trials were started. His research interests are in Health Technology Evaluation including multi-parametric MRI, Histoscanning, Tissue Type Imaging, as well as therapeutic interventions such as high intensity focused ultrasound, irreversible electroporation, photodynamic therapy, cryotherapy and radiofrequency ablation. He has completed numerous phase I/II clinical trials evaluating the role of focal therapy in prostate cancer and is lead PI and Co-PI in a number of multicentre trials including the UK NIHR-HTA funded study NCRN PROMIS study evaluating the role of multi-parametric MRI in men with a raised PSA using Template Prostate Mapping as the reference standard as well as NCRN INDEX, a multicentre focal therapy study using HIFU with 3 year follow-up and NCRN FORECAST. He previously held a £1.2M MRC Clinician Scientist Fellowship for 5 years and currently holds a £2M Senior Clinical Research Fellowship from the Wellcome Trust. His total grant income is £5M as lead applicant and £8M in total as co-applicant.
研究兴趣
论文共 679 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
European Urologyno. 1 (2024): 35-46
European Urology (2024): S1407-S1408
Journal of nuclear medicine : official publication, Society of Nuclear Medicineno. 3 (2024): 379-385
Mayor N., Salih A., Inder M.,Light A.J.W.,Eldred-Evans D.,Bertoncelli Tanaka M.,Connor M.J.,Shah T.T.,Ahmed H.U.
European Urology (2024): S2174-S2175
BRITISH JOURNAL OF GENERAL PRACTICEno. 745 (2024): BJGP.2023.0083-BJGP.2023.0083
BJU INTERNATIONALno. 1 (2024): 112-117
加载更多
作者统计
#Papers: 688
#Citation: 18160
H-Index: 67
G-Index: 120
Sociability: 8
Diversity: 3
Activity: 186
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn